Prehn and Main (1957), having recognized cross-immunity among syngeneic tumors to a certain degree in their earlier works, laid ardent hopes on studies of cancer immunity. But the existence of cross-immunity could not be confirmed in later studies, so it was concluded that cross-immunity among syngeneic tumors did not generally exist (Prehn 1962) . Klein et al. (1960) insisted on the indi viduality of the antigenicity of chemically induced tumors, because of the failure of trial to inhibit syngeneic transplantation by cross-immunity. Since then, it is the current consensus that cross-immunity due to the common antigens does not exist among chemically induced tumors, although it exists among viral tumors (Prehn 1965 , Klein 1968 . Recently, Zbar et al. (1969) reported that 3 of 8 diethylnitrosa mine-induced strain-2 guinea pig hepatomas contained cross-reacting tumor-specific transplantation antigens (TSTA). Holmes et al. (1971) also reported that crossreacting TSTA were demonstrated in 2 of 3 MCA-induced strain-2 guinea pig sarcomas. In our previous paper, it was reported that cross-immunity was observ ed among various ascites tumors of non-inbred rats (Usubuchi et al. 1972) . And, as all hosts implanted intraperitoneally with these various ascites tumors died from the proliferation of tumor cells in spite of immunization with all sorts of organs of the rat other than tumor cells, this cross-immunity must be considered to be due to a common antigenicity among these tumors.
In this report we present the results of studies not only of the existence of cross-immunity among mammary carcinomas and that between mammary carci noma and MCA-induced sarcomas of C3H/He mice, but also of the inhibition of autologous transplantation of primary mammary carcinoma by using crossimmunity.
MATERIALS AND METHODS
C3H/He mice of both sexes, weighing approximately 20 g, were obtained from the Laboratory of Animal Science of Hirosaki University, to which the originals had been supplied by the National Institute of Genetics, Mishima. Two spontaneous C3H/He mouse mammary carcinomas, designated C-1 and C-2, and 2 MCA-induced C3H/He mouse sar comas, designated S-1 and S-2, were used. Each of these tumors was maintained subcutaneously by serial transplantation in this department for about 1 year.
Immunization was usually performed by the inoculation of a fragment of the tumor into the subcutaneous tissue of the mouse with the use of a sterile 12-gauge trocar. When the engrafted tumors reached a size of approximately 10 mm, surgical excision or ligation and-release was done. Some of these inoculated tumors showed spontaneous regression. In the same way, the challenging tumor was inoculated into the subcutaneous tissue of the dorsum of the test mice 2 to 3 weeks after the immunizing procedure.
In experiment 1 (Table 1) , C-1 was challenged by inoculating to the mice after surgical excision or spontaneous regression of each of the immunizing tumors (C-1, C-2, S-1 and S-2). In experiment 2 (Table 2) , after being cured of the immunizing tumor (G-1) by ligation-and-release, the same tumor was challenged. In experiment 3 (Table 3 ), C-I was challenged to the mice after curing the immunizing tumor (S-1) by ligation-andrelease, or after the spontaneous regression of the immunizing tumor (S-1). In experiment 4 ( Table 4) , inhibition of autologous transplantation of the primary carcinoma was undertaken. The primary carcinoma was completely removed and stored in the subcutaneous tissue of other animals of the strain of origin. The primary host was immunized with S-1 or S-2. After the growing implant was conditioned by spontaneous regression, excision or ligation-and-release, the primary mammary carcinoma was inoculated into the dorsal subcutaneous tissue of the primary host. Non-immunized animals of control groups were treated in the same way as in each of these 4 experiments respectively. RESULTS Exp. 1. Results of C-1 challenge to the mice immunized with various syngeneic tumors (Table 1) The percentage of takes in C-1 challenge to the non-immunized control mice was 1.00 per cent in each of 4 groups of Exp. 1, in which the immunizing tumor used was C-1, C-2, S-1 or S-2. The percentage of takes of C-1 challenge to the mice, in which the excision of the immunizing tumor had been performed, was 75 to 90 per cent, and that of C-1 challenge to the mice, in which the immunizing tumor had resulted in spontaneous regression, was 29 to 54 per cent. In group 1, the immunizing and challenging tumors were identical. In groups 2, 3 and 4, the immunizing and challenging tumors were different. Exp. 2. Results of C-I challenge to the mice immunized by ligation-and-release of C-1 (Table 2) The experiments were repeated 5 times. Exp. 3. Results of C-1 challenge to the mice immunized with ,S-1 which resulted in spontaneous regression or were conditioned with ligation-and-release (Table 3) The experiments were repeated 2 times. The percentage of takes of nonimmunized controls was 93 per cent. The percentage of takes was 74 per cent in the mice conditioned with ligation-and-release, while the ratio was 29 per cent in the mice, in which the immunizing tumor had resulted in spontaneous regression. 
DISCUSSION
In Exp. 1, in which 2 strains of mammary carcinoma (C-1 and C-2) and 2 strains of MCA-induced sarcoma (S-1 and S-2) were used for immunization, the challenge was made with C-l. As shown in Table 1 , no difference in degree of immunization was demonstrated between cases in which the immunizing and challenging tumors were identical and those in which the immunizing and challeng ing tumors were different. In our previous paper which dealt with cross-immunity among various allogeneic tumors of non-inbred rats, it was reported that crossimmunity was established among various allogeneic tumors, and that the degree of immunization was shown more effectively in cases in which the immunizing and challenging tumors were identical than in cases in which the immunizing and challenging tumors were different (Usubuchi et al. 1972) . In the present studies employing syngeneic tumors, the difference could not be made clear. This may be explained by the fact that antigeneic differences in allogeneic tumors are more marked than those in syngeneic tumors. The other finding of these experiments was that resistance was brought about most effectively in cases, in which the immunizing tumor resulted in spontaneous regression. The effect of immunization by ligation-and-release in Exp. 2 and 3 was also weak as compared with that in the case of spontaneous regression. These experiments also gave support to the fact that immunization with different syngeneic tumors was approximately as effective as that with the same tumor. Exp. 4 deals with inhibition of autologous transplantation of primary mammary carcinoma by taking advantage of the cross-immunity recog nized among syngeneic tumors. The result is recorded in Table 4 , which shows that autologous transplantation of primary tumors was inhibited by cross immunity in the case of spontaneous regression of the immunizing tumor. The immnuizing procedure of excision or ligation-and-release of the tumor failed to bring about marked inhibition of autologous transplantation. This is considered to be a natural outcome, because the most effective immunity seems to be given by the spontaneous regression of the immunizing tumor, as perceived from the results of Exps. 1, 2 and 3. If there is common antigenicity among syngeneic tumors, the inhibition of autologous transplantation by immunization with syngeneic tumors may be explained easily. The idea was demonstrated in the present studies. Furthermore, Usubuchi (1956) described some inhibitory effect of cross-immunity on MCA-carcinogenesis using tumor tissues and normal imma ture cells as antigens. It is evident that more data will be required before the inhibitory effect of cross-immunity on the production of tumors can be assessed. Prehn (1961) reported the failure of immunization against tumorigenesis.
The mammary carcinoma of C3H/He mice used in a series of present experi ments is a viral tumor. Although cross-immunity between viral tumors might be caused by the presence of viruses, the cross-immunity between mammary carcinoma and MCA-induced sarcoma cannot be explained by the presence of viruses. Moreover, since it was shown in our previous paper that immunity was observed among various non-viral tumors of non-inbred rats (Usubuchi et al. 1972) , the cross-immunity among tumors of C3H/He mice seems to be unrelated to the presence of viruses,
